                         SEQUENCE LISTING

<110>  INSERM
 
<120>  METHODS OF TREATMENT OF CANCER DISEASE BY TARGETING AN EPIGENETIC
        FACTOR

<130>  BIO19474 MULLIGAN/AF

<160>  4     

<170>  PatentIn version 3.3

<210>  1
<211>  506
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Ala Ser Gly Asp Leu Tyr Glu Val Glu Arg Ile Val Asp Lys Arg 
1               5                   10                  15      


Lys Asn Lys Lys Gly Lys Trp Glu Tyr Leu Ile Arg Trp Lys Gly Tyr 
            20                  25                  30          


Gly Ser Thr Glu Asp Thr Trp Glu Pro Glu His His Leu Leu His Cys 
        35                  40                  45              


Glu Glu Phe Ile Asp Glu Phe Asn Gly Leu His Met Ser Lys Asp Lys 
    50                  55                  60                  


Arg Ile Lys Ser Gly Lys Gln Ser Ser Thr Ser Lys Leu Leu Arg Asp 
65                  70                  75                  80  


Ser Arg Gly Pro Ser Val Glu Lys Leu Ser His Arg Pro Ser Asp Pro 
                85                  90                  95      


Gly Lys Ser Lys Gly Thr Ser His Lys Arg Lys Arg Ile Asn Pro Pro 
            100                 105                 110         


Leu Ala Lys Pro Lys Lys Gly Tyr Ser Gly Lys Pro Ser Ser Gly Gly 
        115                 120                 125             


Asp Arg Ala Thr Lys Thr Val Ser Tyr Arg Thr Thr Pro Ser Gly Leu 
    130                 135                 140                 


Gln Ile Met Pro Leu Lys Lys Ser Gln Asn Gly Met Glu Asn Gly Asp 
145                 150                 155                 160 


Ala Gly Ser Glu Lys Asp Glu Arg His Phe Gly Asn Gly Ser His Gln 
                165                 170                 175     


Pro Gly Leu Asp Leu Asn Asp His Val Gly Glu Gln Asp Met Gly Glu 
            180                 185                 190         


Cys Asp Val Asn His Ala Thr Leu Ala Glu Asn Gly Leu Gly Ser Ala 
        195                 200                 205             


Leu Thr Asn Gly Gly Leu Asn Leu His Ser Pro Val Lys Arg Lys Leu 
    210                 215                 220                 


Glu Ala Glu Lys Asp Tyr Val Phe Asp Lys Arg Leu Arg Tyr Ser Val 
225                 230                 235                 240 


Arg Gln Asn Glu Ser Asn Cys Arg Phe Arg Asp Ile Val Val Arg Lys 
                245                 250                 255     


Glu Glu Gly Phe Thr His Ile Leu Leu Ser Ser Gln Thr Ser Asp Asn 
            260                 265                 270         


Asn Ala Leu Thr Pro Glu Ile Met Lys Glu Val Arg Arg Ala Leu Cys 
        275                 280                 285             


Asn Ala Ala Thr Asp Asp Ser Lys Leu Leu Leu Leu Ser Ala Val Gly 
    290                 295                 300                 


Ser Val Phe Cys Ser Gly Leu Asp Tyr Ser Tyr Leu Ile Gly Arg Leu 
305                 310                 315                 320 


Ser Ser Asp Arg Arg Lys Glu Ser Thr Arg Ile Ala Glu Ala Ile Arg 
                325                 330                 335     


Asp Phe Val Lys Ala Phe Ile Gln Phe Lys Lys Pro Ile Val Val Ala 
            340                 345                 350         


Ile Asn Gly Pro Ala Leu Gly Leu Gly Ala Ser Ile Leu Pro Leu Cys 
        355                 360                 365             


Asp Ile Val Trp Ala Ser Glu Lys Ala Trp Phe Gln Thr Pro Tyr Ala 
    370                 375                 380                 


Thr Ile Arg Leu Thr Pro Ala Gly Cys Ser Ser Tyr Thr Phe Pro Gln 
385                 390                 395                 400 


Ile Leu Gly Val Ala Leu Ala Asn Glu Met Leu Phe Cys Gly Arg Lys 
                405                 410                 415     


Leu Thr Ala Gln Glu Ala Cys Ser Arg Gly Leu Val Ser Gln Val Phe 
            420                 425                 430         


Trp Pro Thr Thr Phe Ser Gln Glu Val Met Leu Arg Val Lys Glu Met 
        435                 440                 445             


Ala Ser Cys Ser Ala Val Val Leu Glu Glu Ser Lys Cys Leu Val Arg 
    450                 455                 460                 


Ser Phe Leu Lys Ser Val Leu Glu Asp Val Asn Glu Lys Glu Cys Leu 
465                 470                 475                 480 


Met Leu Lys Gln Leu Trp Ser Ser Ser Lys Gly Leu Asp Ser Leu Phe 
                485                 490                 495     


Ser Tyr Leu Gln Asp Lys Ile Tyr Glu Val 
            500                 505     


<210>  2
<211>  1521
<212>  DNA
<213>  Homo sapiens

<400>  2
atggcttctg gggaccttta cgaggttgaa aggattgtag acaagaggaa gaacaagaaa     60

ggaaaatggg agtatcttat ccgatggaaa ggctacggga gcaccgagga cacgtgggag    120

ccggagcacc acctcttgca ctgtgaggag tttattgatg aattcaatgg gttgcacatg    180

tccaaggaca agaggatcaa gtcagggaag cagtccagta cctccaagct gctgcgtgac    240

agtcgaggcc cgtcggttga gaaactgtcc cacagacctt cagatcctgg aaagagcaag    300

gggacctccc ataaacggaa gcgaattaac cctcccctgg ccaagccaaa aaaagggtat    360

tcaggcaagc cctcttcagg aggtgacagg gccaccaaga cggtgtctta caggactacc    420

cccagtggtt tgcaaataat gcccctgaaa aagtctcaga acgggatgga aaatggggac    480

gccggctctg agaaggatga gaggcacttt ggaaatgggt cccatcagcc tggcttggat    540

ttgaatgatc atgttggaga gcaagatatg ggtgaatgtg acgtgaatca cgctacactg    600

gcggagaacg ggctcggctc tgctctgacc aacgggggat tgaacctgca cagtccagtg    660

aagaggaagc tggaagcgga gaaggactac gtctttgaca aaaggctcag atacagtgtc    720

cgccagaatg aaagcaactg tcggtttcga gacatcgttg tgcggaagga agaagggttc    780

acgcacatcc tgctgtccag tcagacctcg gataacaatg ccctgacacc tgagatcatg    840

aaagaagtcc ggcgagcgct ctgcaacgca gccacagacg acagcaaact gctgctcctc    900

agcgcagtgg ggagcgtgtt ctgcagcggc ctggattatt cctacctaat tggccggttg    960

tccagcgacc ggcgaaagga gagcactcgg attgcagaag ccatcaggga ctttgtgaag   1020

gcctttatcc agtttaagaa gcctatcgtg gtggccatca atgggccggc cctgggcctg   1080

ggtgcctcca tcctgcccct ctgtgacatc gtgtgggcca gtgagaaggc ctggttccag   1140

acgccctacg ccaccatccg cctcacgcct gctggctgct cctcctacac cttcccccag   1200

atcctgggcg tcgcgctggc caatgagatg ctgttctgtg ggcggaagct caccgcccag   1260

gaggcctgca gcagggggct ggtgtcgcag gtcttctggc ccaccacgtt cagccaggag   1320

gtcatgctgc gggtcaagga gatggcatcc tgcagtgccg tggtgttaga ggagtccaaa   1380

tgcctcgtgc ggagcttcct gaaatcagtg ctggaagacg tgaacgagaa ggaatgcctc   1440

atgctcaagc agctctggag ctcctccaaa ggccttgact cccttttcag ctacctgcag   1500

gacaaaattt atgaagtctg a                                             1521


<210>  3
<211>  22
<212>  DNA
<213>  Artificial

<220>
<223>  CDYL2 forward PCR primer

<400>  3
accaacgggg gattgaacct gc                                              22


<210>  4
<211>  25
<212>  DNA
<213>  Artificial

<220>
<223>  CDYL2 PCR reverse primer

<400>  4
ggtgtcaggg cattgttatc cgagg                                           25


